The Platform Group has received the final regulatory clearance required to proceed with the most significant acquisition in its corporate history. Germany’s Federal Cartel Office, the Bundeskartellamt, raised no objections to the company’s planned takeover of pharmaceutical wholesaler AEP GmbH. This approval, granted on March 31, removes a pivotal hurdle, bringing the software firm a step closer to dramatically expanding its revenue scale.
Strategic Shift and Market Impact
This move represents a strategic pivot for The Platform Group. Previously active in the healthcare sector primarily through its ApoNow platform, the acquisition of Alzenau-based AEP positions the group to become a full-service provider. The company’s network already connects approximately 41,000 pharmacies across four countries. Integrating AEP, which recently reported annual revenues exceeding one billion euros, is expected to elevate the group’s value chain to a new level.
Specifically for The Platform Group’s pharmaceutical segment, the deal promises substantial growth. The transaction is projected to boost the division’s volume to an estimated €1.1 billion.
Financing and Timeline
Alongside securing regulatory approval, the company’s management is advancing the financing strategy for the purchase. The plan involves a blend of equity and debt financing with terms spanning three to five years. The board anticipates communicating the final financing structure in May, coinciding with the expected formal closure of the transaction.
Should investors sell immediately? Or is it worth buying The Platform Group?
The remaining contractual conditions are slated to be finalized by the end of May, aiming for formal integration to be completed in the second quarter of 2026.
Investor Sentiment and Share Performance
Despite the expansionary news, the market’s initial reaction has been subdued. Shares of The Platform Group touched a new 52-week low of €2.75 in yesterday’s trading. This suggests investors are adopting a wait-and-see approach, likely seeking more detail on the capital measures and the practical integration of the billion-euro revenue stream before reassessing the growth strategy.
The completion of the deal this quarter will provide clearer indicators of how swiftly operational synergies can be realized.
Ad
The Platform Group Stock: Buy or Sell?! New The Platform Group Analysis from April 3 delivers the answer:
The latest The Platform Group figures speak for themselves: Urgent action needed for The Platform Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 3.
The Platform Group: Buy or sell? Read more here...
